Androgen synthesis and steroid transporters in prostate cancer: rethinking the transition to CRPC.
Pressler
Heather M
HM
Molecular Pharmacology Section, Medical Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Figg
William D
WD
D059002:Androgen Receptor Antagonists; D000728:Androgens / Q000096:biosynthesis* / Q000235:genetics; D002784:Cholesterol / Q000096:biosynthesis; D015870:Gene Expression / Q000187:drug effects; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000188:drug therapy / Q000235:genetics / Q000378:metabolism*; D011944:Receptors, Androgen / Q000187:drug effects / Q000235:genetics; D013739:Testosterone / Q000096:biosynthesis
D059002:Androgen Receptor Antagonists; D000728:Androgens; D011944:Receptors, Androgen; D013739:Testosterone; D002784:Cholesterol